BIO:XETRA Biotest Aktiengesellschaft

EUR 41.60 -0.20 -0.478469
Icon

Biotest Aktiengesellschaft (BIO:XETRA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 41.60

-0.20 (-0.48)%

EUR 1.39B

28.00

N/A

N/A

Icon

BIO:XETRA

Biotest Aktiengesellschaft (EUR)
COMMON STOCK | XETRA
EUR 41.60
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 1.39B

N/A

EUR 41.60

Biotest Aktiengesellschaft (BIO:XETRA) Stock Forecast

N/A

Based on the Biotest Aktiengesellschaft stock forecast from 0 analysts, the average analyst target price for Biotest Aktiengesellschaft is not available over the next 12 months. Biotest Aktiengesellschaft’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Biotest Aktiengesellschaft is Neutral, which is based on 6 positive signals and 7 negative signals. At the last closing, Biotest Aktiengesellschaft’s stock price was EUR 41.60. Biotest Aktiengesellschaft’s stock price has changed by -0.95% over the past week, -2.35% over the past month and -1.89% over the last year.

No recent analyst target price found for Biotest Aktiengesellschaft
No recent average analyst rating found for Biotest Aktiengesellschaft

Company Overview Biotest Aktiengesellschaft

Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the ther...Read More

https://www.biotest.com

Landsteinerstrasse 5, Dreieich, Germany, 63303

2,426

December

EUR

Germany

Adjusted Closing Price for Biotest Aktiengesellschaft (BIO:XETRA)

Loading...

Unadjusted Closing Price for Biotest Aktiengesellschaft (BIO:XETRA)

Loading...

Share Trading Volume for Biotest Aktiengesellschaft Shares

Loading...

Compare Performance of Biotest Aktiengesellschaft Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIO:XETRA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biotest Aktiengesellschaft (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NOV:XETRA
Novo Nordisk A/S +0.24 (+0.21%) EUR515.68B 46.27 4.59

ETFs Containing BIO

Symbol Name BIO's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Biotest Aktiengesellschaft (BIO:XETRA) Stock

Stock Target Advisor's fundamental analysis for Biotest Aktiengesellschaft's stock is Neutral.

Unfortunately we do not have enough data on BIO:XETRA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIO:XETRA's stock to indicate what its average analyst target is.

BIO:XETRA stock's Price/Earning ratio is 13.00. Our analysis grades BIO:XETRA stock's Price / Earning ratio at D. This means that BIO:XETRA stock's Price/Earning ratio is above 37% of the stocks in the Biotechnology sector in the XETRA exchange. Based on this BIO:XETRA may be fairly valued for its sector

The last closing price of BIO:XETRA's stock was EUR 41.60.

The most recent market capitalization for BIO:XETRA is EUR 1.39B.

Unfortunately we do not have enough analyst data on BIO:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Biotest Aktiengesellschaft's stock.

As per our most recent records Biotest Aktiengesellschaft has 2,426 Employees.

Biotest Aktiengesellschaft's registered address is Landsteinerstrasse 5, Dreieich, Germany, 63303. You can get more information about it from Biotest Aktiengesellschaft's website at https://www.biotest.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...